C69.2 Malignant neoplasm of retina

Name of the Condition

• Malignant neoplasm of retina

Summary

This condition refers to cancerous growths originating in the retina, the light-sensitive tissue at the back of the eye responsible for visual processing. It is a rare but serious ocular malignancy that can impair vision and may spread to other parts of the body. The retina’s role in converting light into neural signals makes malignancies here particularly impactful on visual function.

Causes

The exact cause is unknown, but genetic mutations in retinal cells are suspected. Some cases may be linked to environmental factors, though specific triggers are not well-defined. Retinal malignancies often arise from uncontrolled cell growth in the retinal pigment epithelium or photoreceptor layers.

Risk Factors

• Older age.
• Prior radiation exposure to the eye or head.
• Certain genetic syndromes that elevate cancer risk (e.g., hereditary retinoblastoma).
• A history of other eye malignancies or pre-cancerous conditions.
• Light eye color may increase susceptibility.

Symptoms

• Blurred or distorted vision.
• Seeing flashes of light or floaters.
• Loss of peripheral vision (tunnel vision).
• Changes in color perception.
• Visible dark spots or shadows in the visual field.
• Pain or discomfort in advanced cases.
• Sudden vision loss.

Diagnosis

Diagnosis typically involves a thorough eye examination, including dilated funduscopy to assess the retina. Imaging tests like optical coherence tomography (OCT) or fluorescein angiography may be used to evaluate tumor extent. Biopsy of the affected tissue is performed to confirm malignancy, often guided by imaging.

Treatment Options

• Surgery to remove the tumor, if localized and accessible.
• Radiation therapy (e.g., brachytherapy or external beam) to target the tumor while sparing surrounding tissue.
• Chemotherapy (systemic or intraocular) for advanced or metastatic cases.
• Laser therapy to destroy small tumors or abnormal blood vessels.
• Immunotherapy or targeted therapies, depending on tumor characteristics.

Prognosis and Follow-Up

Prognosis depends on the tumor’s size, location, and whether it has spread. Early detection improves outcomes, but advanced cases may have a poorer prognosis. Regular follow-up with eye exams and imaging is essential to monitor for recurrence or metastasis.

Complications

• Permanent vision loss or blindness.
• Tumor spread to other parts of the eye or body (metastasis).
• Retinal detachment.
• Glaucoma or increased intraocular pressure.
• Secondary infections or inflammation.

Lifestyle & Prevention

• Protect eyes from excessive UV light with sunglasses.
• Maintain regular eye exams, especially if at higher risk.
• Avoid known carcinogens (e.g., tobacco smoke) when possible.
• Follow-up care as recommended by a healthcare provider.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, flashes of light, floaters, or pain in the eye. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

When coding for C69.2, ensure documentation specifies the malignant neoplasm of the retina and confirms the diagnosis through clinical findings or biopsy. Note any associated conditions (e.g., retinal detachment) or treatment details to support accurate coding. Verify that the code aligns with the specific anatomical location and malignancy type documented.